Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive cerebellar ataxia in which the cause of the disease is a mutation in the UBA5 gene.
Features include always present findings: Cataract, Shrinkage of the cerebellum (cerebellar atrophy), Dysarthria, and Gait ataxia and others; and common findings: Spastic gait.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Dysarthria, Gait ataxia, Spastic gait |
UBA5 function has not been fully characterized.
Spinocerebellar ataxia, autosomal recessive 24 is associated with mutations in the UBA5 gene on chromosome 3.
Genetic testing for UBA5 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 6 always present features, 1 common feature.
No clinical trials have been registered for spinocerebellar ataxia, autosomal recessive 24.
19 publications have been identified in PubMed for spinocerebellar ataxia, autosomal recessive 24. Research spans Review / Meta-Analysis (32%), Basic Science / Preclinical (26%), and Clinical Trial Publication (21%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 32% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 6:11 PM UTC
Online Mendelian Inheritance in Man
2 |
Cataract, Horizontal nystagmus |
Muscles | 1 | Shrinkage of the cerebellum (cerebellar atrophy) |
Arms and legs | 1 | Limb ataxia |
Laboratory research
5 |
26% |
Clinical study results | 4 | 21% |
Patient case studies | 2 | 11% |
Disease patterns and progression | 2 | 11% |
Jenni R (2026). [PMID: 41715124](https://pubmed.ncbi.nlm.nih.gov/41715124/). *J Transl Med*. [Basic Science / Preclinical]
Lessard I (2025). [PMID: 40095137](https://pubmed.ncbi.nlm.nih.gov/40095137/). *Cerebellum*. [Clinical Trial Publication]
Lessard I (2025). [PMID: 40450178](https://pubmed.ncbi.nlm.nih.gov/40450178/). *Cerebellum*. [Clinical Trial Publication]
De Riso G (2025). [PMID: 39853590](https://pubmed.ncbi.nlm.nih.gov/39853590/). *Cerebellum*. [Basic Science / Preclinical]
Fogel BL (2025). [PMID: 40464291](https://pubmed.ncbi.nlm.nih.gov/40464291/). *Ann Neurol*. [Review / Meta-Analysis]
Novis LE (2025). [PMID: 39920364](https://pubmed.ncbi.nlm.nih.gov/39920364/). *Cerebellum*. [Review / Meta-Analysis]
Salem IH (2025). [PMID: 39753868](https://pubmed.ncbi.nlm.nih.gov/39753868/). *Cerebellum*. [Review / Meta-Analysis]
Masson LC (2025). [PMID: 40372562](https://pubmed.ncbi.nlm.nih.gov/40372562/). *Cerebellum*. [Basic Science / Preclinical]
Lima SM (2025). [PMID: 41176519](https://pubmed.ncbi.nlm.nih.gov/41176519/). *J Neurol*. [Epidemiology / Natural History]
Ahmad R (2025). [PMID: 40858856](https://pubmed.ncbi.nlm.nih.gov/40858856/). *Cerebellum*. [Basic Science / Preclinical]